Clinical Trial Update: First in Human Study of M4344 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial of M4344 in participants with advanced solid tumors completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• M4344

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Solid Tumor, Advanced Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2023-03-16